Third Harmonic Bio Inc THRD

$5.38 -0.01 (-0.09%)

Valuation

Market cap
242,789,000
Revenue TTM
$0
Net income TTM
$-45,470,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
1,417,900
Avg volume
264,952
Day's range
$5.34 – $5.43
Shares out
45,128,000
Stochastic %K
26%
Beta
2.12
Analysts
Hold
Price target
$3.00

Price

Company profile

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It also develops THB335, an oral small molecule KIT inhibitor for the treatment...

Show more

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It also develops THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated inflammatory diseases, respiratory, and gastrointestinal conditions. It has a license agreement with Novartis Pharma AG. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California.

Industry
Biotechnology
Sector
Healthcare
Phone
209 727 2457
Website
https://www.thirdharmonicbio.com
Address
1700 Montgomery Street, Suite 210, San Francisco, United States

Latest news

Stocktwits

RichboyZan Nov 9, 11:19 AM
$THRD I’m interested in whether that momentum sticks
0 replies
Armonica423 May 10, 6:16 PM
$THRD Big exposure for CYDY at 3 oncology conferences this coming week, do Your dd research
0 replies
Quantumup May 6, 3:51 PM
Cantor Fitzgerald reiterated $CLDX Overweight-$67. $SNY $BPMC $JSPR $THRD Cantor Fitzgerald said, "We view the upcoming EoE data as an important catalyst for the stock, not yet baked into the valuation given Celldex is spearheading the research for understanding the clinical role in targeting mast cells in EoE. Sanofi (SNY, NC) estimates that there are ~100K biologic-eligible EoE patients in the U.S. + EU5. Showing the potential utility of barzolvolimab in EoE could also help de-risk multiple other follow-on opportunities and give some optionality for potential barzolvolimab expansion." Cantor Fitzgerald $CLDX - February 20, 2020: https://x.com/Quantumup1/status/1230603833463726081 Cantor Fitzgerald $CLDX - July 1, 2020: https://x.com/Quantumup1/status/1278327745227915272
0 replies
rocksteadystocks Apr 28, 1:46 PM
$THRD are you going to fade any time soon. your fighting it come rock with us
0 replies
DiamondCapital Apr 21, 2:49 PM
$PRSO mentioned in this news article last week along with $BULL, $THRD, $XAGE, $HIT also mentioned in the article https://x.com/stockpicksnyc/status/1914330464078254204?s=46 Peraso Inc. (NASDAQ: PRSO) Surges on Game-Changing Patent – More Stocks Inside Link to article: https://thestreetreports.com/peraso-inc-nasdaq-prso-surges-late-friday-on-game-changing-patent-more-stocks-inside/
0 replies
theflynews Apr 16, 4:01 PM
Biotech Alert: Searches spiking for these stocks today - $THRD - https://thefly.com/permalinks/entry.php/THRDid4108013?1744818738C38
0 replies
topstockalerts Apr 14, 10:25 PM
Todays Top Gainers PT2 $TMC $USAR $MB $THRD $WXM
0 replies
rocksteadystocks Apr 14, 9:34 PM
$THRD After Action Review Money Making Monday - $THRD – “Was like watching paint dry or something worse." Play Type: Slow consolidation / News-based short. Had a Channel from $5.05 to $5.10 This plan includes the sale of its assets, such as the THB335 program, and the delisting of its shares from Nasdaq upon filing a Certificate of Dissolution, pending stockholder approval at the annual meeting on June 5, 2025. Trade Breakdown: ****Open: $5.10 ****First Trade short position off the news. Entry: $5.01 average First Exit: Still in the trade Stop Loss: $5.30 ****Outcome: Still in Note: Missed other opportunities while watching this slow grinder like $BULL and . Tight range, not much volatility = high probability of fakeouts. HOD $5.13 Come Rock With Us.. #daytrader #bitcoin #option #swingtrade #forex #invest #stocks #stockmarket #smallcap #optiontrading #investing #stockstrader #rocksteadystocks #comerockwithus #earningsseason #Earnings #52weekhigh #52weeklow #long #shorts
0 replies